Abstract
This brief review summarizes various schemes which were introduced to classify pituitary tumors of adenohypophysial origin. Many different classifications were proposed. Pathologists prefer classifications based on the morphologic features of tumor cells. The gold standard is the light microscopic study of hematoxylin–eosin stained sections of formalin fixed and paraffin-embedded tissues. For correlation between hormone production, secretory activity and cytogenesis, immunohistochemical and transmission electron microscopic investigation is needed. We are convinced that in the future, molecular and genetic techniques will also be applied. We present here our five-tier scheme for classification of pituitary tumors which was accepted by the ‘World Health Organization International Histological Classification of Tumours’. This classification takes into consideration the clinical and laboratory findings, imaging results, histologic, immunocytochemical and ultrastructural features of tumor cells. Despite several recent attempts to assess the growth rate, aggressiveness and invasiveness of pituitary tumors, more work is required to draw conclusions on their prognosis.
Similar content being viewed by others
References
Aron DC, Howlett TA: Pituitary incidentalomas. Endocrinol Metab Clin North Am 29: 205–221, 2000
Asa SL: The pathology of pituitary tumors. Endocrinol Metab Clin North Am 28: 13–43, 1999
Asa SL: Tumors of the pituitary gland. Atlas of tumor pathology 3rd series. Fascicle 22 Armed Forces Institute of Pathology, Washington DC, 1999, pp 1–214
Asa SL, Ezzat S: The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19: 798–827, 1998
Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD: Thyrotropin-secreting pituitary tumors. Endocr Rev 17: 610–638, 1996
Dahia PL, Grossman AB: The molecular pathogenesis of corticotroph tumors. Endocr Rev 20: 136–155, 1999
Farrell WE, Clayton RN: Tumour suppressor genes in pituitary tumour formation. Baillieres Best Pract Res Clin Endocrinol Metab 13: 381–393, 1999
Farrell WE, Clayton RN: Molecular pathogenesis of pituitary tumors. Front Neuroendocrinol 21: 174–198, 2000
Freda PU, Post KD: Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am 28: 81–117, 1999
Freda PU, Wardlaw SL: Clinical review 110: Diagnosis and treatment of pituitary tumors. J Clin Endocrinol Metab 84: 3859–3866, 1999
Heaney AP, Melmed S: New pituitary oncogenes. Endocr Relat Cancer 7: 3–15, 2000
Horvath E, Kovacs K: The adenohypophysis. In: Kovacs K, Asa SL (eds) Functional endocrine pathology, 2nd edn. Blackwell Sciences, Boston, Maryland, 1998, pp 247–281
Horvath E, Kovacs K, Scheithauer BW: Pituitary hyperplasia. Pituitary 1: 169–180, 2000
Horvath E, Lloyd RV, Kovacs K: Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells. A morphologic study of the rat pituitary including immunoelectron microscopy. Lab Invest 63: 511–520, 1990
Horvath E, Scheithauer BW, Kovacs K, Lloyd RV: Regional neuropathology: hypothalamus and pituitary. In: Graham DI, Lantos PL (eds) Greenfield's neuropathology, 6th edn. Arnold, London, England, 1997, pp 1007–1094
Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW: Vasculature in nontumorous hypophysis, pituitary adenomas, and carcinomas: a quantitative morphologic study. Endocrine Pathol 6: 115–124, 1995
Kovacs K: Molecular biological research in pituitary adenomas from the pathologists’ view. Acta Neurochir Suppl (Wien) 65: 4–6, 1996
Kovacs K, Horvath E: Tumors of the pituitary gland. Atlas of tumor pathology 2nd series. Fascicle 21 Armed Forces Institute of Pathology, Washington DC, 1986, pp 1–269
Kovacs K, Scheithauer BW, Horvath E, Lloyd RV: The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme. Cancer 78: 502–510, 1996
Lafferty AR, Chrousos GP: Pituitary tumors in children and adolescents. J Clin Endocrinol Metab 84: 4317–4323, 1999
Laws ER Jr, Thapar K: Pituitary surgery. Endocrinol Metab Clin North Am 28: 119–131, 1999
Lloyd RV, Osamura RY: Transcription factors in normal and neoplastic pituitary tissues. Microsc Res Tech 39: 168–181, 1997
Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L: Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocrine Pathol 10: 229–235, 1999
Melmed S: Pathogenesis of pituitary tumors. Endocrinol Metab Clin North Am 28: 1–12, 1999
Missale C, Spano PF: Growth factors in the pathogenesis of prolactin-secreting tumors. J Endocrinol Invest 21: 402–411, 1998
Pernicone PJ, Scheithauer BW, Sebo TJ, Kovacs KT, Horvath E, Young WF Jr, Lloyd RV, Davis DH, Guthrie BL, Schoene WC: Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79: 804–812, 1997
Ray D, Melmed S: Pituitary cytokine and growth factor expression and action. Endocr Rev 18: 206–228, 1997
Saeger W: Current pathological classification of pituitary adenomas. Acta Neurochir Suppl (Wien) 65: 1–3, 1996
Sanno N, Teramoto A, Osamura Y: Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg 93: 194–200, 2000
Scheithauer BW, Horvath E, Kovacs K, Lloyd RV: Tumors of the adenohypophysis. In: Solcia E, Kl¨oppel G, Sobin LH (eds) Histological typing of endocrine tumours, 2nd edn. World Health Organization international histological classification of tumours. Springer, Berlin, 2000, pp 15–29
Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, Laws ER, Young WF: Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 47: 723–730, 2000
Shimon I, Melmed S: Genetic basis of endocrine disease: pituitary tumor pathogenesis. J Clin Endocrinol Metab 82: 1675–1681, 1997
Shimon I, Melmed S: Management of pituitary tumors. Ann Intern Med 129: 472–483,1998
Spada A, Lania A, Mantovani S: Cellular abnormalities in pituitary tumors. Metabolism 45: 46–48, 1996
Suhardja AS, Kovacs KT, Rutka JT: Molecular pathogenesis of pituitary adenomas: a review. Acta Neurochir (Wien) 141: 729–736, 1999
Tada M, Kobayashi H, Moriuchi T: Molecular basis of pituitary oncogenesis. J Neuro-Oncol 45: 83–96, 1999
Thapar K, Kovacs K, Laws ER: The classification and molecular biology of pituitary adenomas. Adv Tech Stand Neurosurg 22: 3–53, 1995
Thapar K, Kovacs K, Muller PJ: Clinical-pathological correlations of pituitary tumours. Baillieres Clin Endocrinol Metab 9: 243–270, 1995
Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER Jr: Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38: 99–107, 1996
Tsagarakis S, Kontogeorgos G, Kovacs K: The role of cytokines in the normal and neoplastic pituitary. Crit Rev Oncol Hematol 28: 73–90, 1998
Turner HE, Adams CB, Wass JA: Pituitary tumours in the elderly: a 20 year experience. Eur J Endocrinol 140: 383–389, 1999
Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA: Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. J Endocrinol 165: 475–481, 2000
Turner HE, Wass JA: Pituitary tumours in the elderly. Baillieres Clin Endocrinol Metab 11: 407–422, 1997
Vance ML: Nonfunctioning pituitary adenoma. Curr Ther Endocrinol Metab 6: 33–35, 1997
Vidal S, Horvath E, Kovacs K: Application of transmission electron microscopy and immunoelectron microscopy in endocrine pathology. Microsc Analysis 64: 21–24, 2000
Vidal S, Horvath E, Kovacs K, Cohen SM, Lloyd RV, Scheithauer BW: Transdifferentiation of somatotrophs to thyrotrophs in the pituitary of patients with protracted primary hypothyroidism. Virchows Arch 436: 43–51, 2000
Vidal S, Scheithauer BW, Kovacs K: Vascularity in nontumorous human pituitaries and incidental microadenomas. A morphometric study. Endocrine Pathol (in press).
Yeh PJ, Chen JW: Pituitary tumors: surgical and medical management. Surg Oncol 6: 67–92, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kovacs, K., Horvath, E. & Vidal, S. Classification of pituitary adenomas. J Neurooncol 54, 121–127 (2001). https://doi.org/10.1023/A:1012945129981
Issue Date:
DOI: https://doi.org/10.1023/A:1012945129981